[kc_row use_container=”yes” force=”no” column_align=”middle” video_mute=”no” _id=”712403″][kc_column width=”12/12″ video_mute=”no” _id=”186826″][kc_column_text _id=”759851″]
A Familial Cluster of Pneumonia Associated With the 2019 Novel Coronavirus Indicating Person-To-Person Transmission A Study of a Family Cluster-31986261.pdf
Algorithm for symptomatic staff, symptomatic household testing and further actions_Royal College Pathologists.pdf
Angiotensinconverting Enzyme 2 ACE2 SARC CoV2 Receptor Molecular Mechanisms and Potential Therapeutic Target-32125455.pdf
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19?-32171062.pdf
Asymptomatic Patients with Novel Coronavirus Disease (COVID-19)-32279479.pdf
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-32278361.pdf
Cancer Patients in SARS-CoV-2 Infection A Nationwide Analysis in China-32066541.pdf
Care of patients with Pulmonary Arterial Hypertension during the Coronavirus (COVID-19) Pandemic- 10.1177/2045894020920153.pdf
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy-32203977.pdf
Clinical Characteristics of 113 Deceased Patients With Coronavirus Disease 2019 Retrospective Study-32217556.pdf
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China-32031570.pdf
Clinical Characteristics of Coronavirus Disease 2019 in China-32109013.pdf
Clinical Characteristics of Novel Coronavirus Cases in Tertiary Hospitals in Hubei Province-32044814.pdf
Clinical Course and Outcomes of Critically Ill Patients With SARS-CoV-2 Pneumonia in Wuhan, China A Single-Centered, Retrospective, Observational Study-32105632.pdf
Clinical Course and Risk Factors for Mortality of Adult Inpatients With COVID-19 in Wuhan, China A Retrospective Cohort Study-32171076.pdf
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study-32242738.pdf
Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China-31986264.pdf
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19-32268022.pdf
Comorbidities in COVID-19 Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers-32283499.pdf
Coronavirus disease 2019 (COVID-19) a clinical update-32240462.pdf
Covid Reference-esp-2020-01-libro.pdf
COVID-19 and Diabetes Knowledge in Progress-32278764.pdf
Covid-19 attacks 1-beta chain hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism.pdf
COVID-19 Illness in Native and Immunosuppressed States. A Clinical-Therapeutic Staging Proposal_Pre proof.pdf
Endothelial cell infection and endotheliitis in COVID-19.zip
Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China A Descriptive Study-32007143.pdf
Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington-32220208.pdf
Exploring possible mechanisms for COVID-19 induced thrombocytopenia Unanswered Questions-32278338.pdf
Facts and reflections on COVID-19 and anti-hypertensivres drugs-32213760.pdf
Guidance for Corona Virus Disease 2019. Prevention, Control, Diagnosis and Management-National Health Commission (NHC) of the PRC.pdf
Hypertension and COVID-19-32251498.pdf
Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19) a pooled analysis-32231171.pdf
Infectividad del paciente con COVID-19 según la severidad de la enfermedad_PREEVID.pdf
Mild or Moderate Covid-19_32329974.pdf
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19-32283162.pdf
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area-32320003.pdf
Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19- a Systematic Review and MetaAnalysis-32232218.pdf
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia-32271988.pdf
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China-32167524.pdf
Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China-32361738.pdf
SAA is a biomarker to distinguish the severity and prognosis of Coronavirus Disease 2019 (COVID-19)-32277967.pdf
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection_ 32336612.pdf
Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection-32200654.pdf
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020_retrospective cohort study_32317267.pdf
[/kc_column_text][/kc_column][/kc_row]
